#China #Hangzhou #Ridgetech #Dual-Engine #Jiuxin Medicine

Ridgetech Strengthens its Position in Pharmaceuticals

Ridgetech, Inc. (Nasdaq: RDGT) is making headlines as it embraces a pivotal role in the pharmaceutical ecosystem through its appointment as a vice-president in the Hangzhou Qiantang District Biomedical and Cosmetic High-Quality Development Association. This significant milestone follows the election of its subsidiary, Zhejiang Jiuxin Medicine Co., Ltd., which will play a crucial part in advancing the biomedical sector in Zhejiang Province.

An Industry Milestone

On July 24, 2026, Ridgetech announced its new role with the Association, which aims to foster high-quality growth in pharmaceuticals, medical devices, and cosmetics. The official inauguration of the Assembly is scheduled for July 28, 2026.

This recognition serves not only as an acknowledgment of Jiuxin Medicine’s innovative initiatives but also highlights its commitment to enhancing transparency within the pharmaceutical supply chain through the implementation of full-variety drug traceability code scanning across Zhejiang Province. Such measures have been validated during a recent inspection by regulators from the Zhejiang Medical Products Administration (MPA), who praised Jiuxin Medicine’s operational effectiveness and encouraged its ongoing efforts in fostering collaboration for developing a province-wide traceability framework.

Technology at the Forefront

Ridgetech operates under a dual-engine strategy that includes Jiuxin Medicine’s B2B distribution and Allright (Hangzhou) Internet Technology Co., Ltd., its online healthcare product distribution platform. The integration and collaboration between these two entities are central to Ridgetech’s growth strategy.

Jiuxin Medicine utilizes cutting-edge technologies such as AI and big data analytics to ensure real-time monitoring of drug distribution. By incorporating traceability code systems, Jiuxin Medicine is equipped to identify, intercept, and track pharmaceutical products efficiently throughout the supply chain. Furthermore, there’s a strategic focus on optimizing distribution processes by identifying bottlenecks in real-time, making it an essential player in enhancing the overall efficiency of the pharmaceutical ecosystem.

Driving National Drug Traceability Reform

Zhejiang Province is among the forerunners in China’s drive for comprehensive drug traceability reform. The new traceability framework introduced requires the tracking of pharmaceutical products throughout their lifecycle, ensuring that all stages from manufacturer shipment to final dispensing at pharmacies or hospitals are documented using unique electronic identifiers.

This stringent tracking protocol, known as the traceability code scan, aids healthcare providers in maintaining compliance and elevates accountability across the pharmaceutical supply chain, thereby enhancing patient safety and product integrity.

Management's Vision

Frank Zhao, the Interim CEO and CFO of Ridgetech, expressed pride in Jiuxin Medicine's newly acquired status, emphasizing that it serves as both an acknowledgment of past achievements and a motivational push for future initiatives. He stated, “As Zhejiang advances drug traceability reform, we are committed to compliance, innovation, and operational excellence.” The strategic framework laid out by Ridgetech is expected to capture synergies across the pharmaceutical value chain, allowing further integration of emerging technologies.

Ridgetech's proactive approach places it in a strong position to navigate the evolving landscape of the pharmaceutical industry. The integration of technological advancements into operational framework not only aligns with industry growth trends but also addresses pressing issues of efficiency and traceability.

The company continues to embrace opportunities provided within China’s vast pharmaceutical market, positioning itself for sustainable growth.

About Ridgetech, Inc.

Ridgetech is a comprehensive distributor of pharmaceutical and healthcare products, utilizing both online and offline platforms. By engaging actively on popular online distribution networks, Ridgetech seeks to expand its reach and optimize the distribution of pharmaceutical products across China. For further information, visit www.ridgetech.com. The company's commitment to transparency and efficiency continues to play a significant role in shaping the future of pharmaceutical distribution in China.